These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 25543511)
1. [Recent advances of studies on the therapy-related myelodysplastic syndromes/acute myeloid leukemia]. Li CJ; Zhang YZ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1757-60. PubMed ID: 25543511 [TBL] [Abstract][Full Text] [Related]
2. Recent advances in the management of therapy-related myelodysplastic syndromes and acute myeloid leukemia. Klimek VM Curr Opin Hematol; 2013 Mar; 20(2):137-43. PubMed ID: 23343830 [TBL] [Abstract][Full Text] [Related]
3. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience. Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450 [TBL] [Abstract][Full Text] [Related]
4. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy. Carney DA; Westerman DA; Tam CS; Milner A; Prince HM; Kenealy M; Wolf M; Januszewicz EH; Ritchie D; Came N; Seymour JF Leukemia; 2010 Dec; 24(12):2056-62. PubMed ID: 20962860 [TBL] [Abstract][Full Text] [Related]
5. Pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia: the MD Anderson Cancer Center experience. Aguilera DG; Vaklavas C; Tsimberidou AM; Wen S; Medeiros LJ; Corey SJ J Pediatr Hematol Oncol; 2009 Nov; 31(11):803-11. PubMed ID: 19801947 [TBL] [Abstract][Full Text] [Related]
6. Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML. Nevill TJ; Hogge DE; Toze CL; Nantel SH; Power MM; Abou Mourad YR; Song KW; Lavoie JC; Forrest DL; Barnett MJ; Shepherd JD; Nitta JY; Wong S; Sutherland HJ; Smith CA Bone Marrow Transplant; 2008 Nov; 42(10):659-66. PubMed ID: 18679372 [TBL] [Abstract][Full Text] [Related]
7. Secondary acute myeloid leukemia - a single center experience. Szotkowski T; Rohon P; Zapletalova L; Sicova K; Hubacek J; Indrak K Neoplasma; 2010; 57(2):170-8. PubMed ID: 20099982 [TBL] [Abstract][Full Text] [Related]
8. Natural killer cell (NK) subsets and NK-like T-cell populations in acute myeloid leukemias and myelodysplastic syndromes. Aggarwal N; Swerdlow SH; TenEyck SP; Boyiadzis M; Felgar RE Cytometry B Clin Cytom; 2016 Jul; 90(4):349-57. PubMed ID: 26648320 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study. Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885 [TBL] [Abstract][Full Text] [Related]
10. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study. Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433 [TBL] [Abstract][Full Text] [Related]
11. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group. Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V; J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650 [TBL] [Abstract][Full Text] [Related]
14. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases. Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Fu B; Tang G; Goswami M; Singh R; Kanagal-Shamanna R; Pierce SA; Young KH; Kantarjian HM; Medeiros LJ; Luthra R; Wang SA Leuk Res; 2015 Mar; 39(3):348-54. PubMed ID: 25573287 [TBL] [Abstract][Full Text] [Related]
15. Therapy-related myeloid neoplasms resembling juvenile myelomonocytic leukemia: a case series and review of the literature. Wintering A; Smith S; Fuh B; Rangaswami A; Dahl G; Chien M; Gruber TA; Dang J; Li LS; Lenzen A; Savelli S; Dvorak CC; Agrawal AK; Stieglitz E Pediatr Blood Cancer; 2022 May; 69(5):e29499. PubMed ID: 34939322 [TBL] [Abstract][Full Text] [Related]
16. Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms. Greco M; D'Alò F; Scardocci A; Criscuolo M; Fabiani E; Guidi F; Di Ruscio A; Migliara G; Pagano L; Fianchi L; Chiusolo P; Hohaus S; Leone G; Voso MT Blood Cells Mol Dis; 2010 Oct; 45(3):181-5. PubMed ID: 20655775 [TBL] [Abstract][Full Text] [Related]
17. The New Clinicopathologic and Molecular Findings in Myeloid Neoplasms With inv(3)(q21q26)/t(3;3)(q21;q26.2). Wang HY; Rashidi HH Arch Pathol Lab Med; 2016 Dec; 140(12):1404-1410. PubMed ID: 27628325 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders. Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathological aspects of therapy-related acute myeloid leukemia and myelodysplastic syndrome. Chua CC; Fleming S; Wei AH Best Pract Res Clin Haematol; 2019 Mar; 32(1):3-12. PubMed ID: 30927972 [TBL] [Abstract][Full Text] [Related]
20. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms. Vardiman JW Chem Biol Interact; 2010 Mar; 184(1-2):16-20. PubMed ID: 19857474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]